By Andrea Figueras Roche said that the European Commission approved Tecentriq SC, a cancer immunotherapy subcutaneous injection for multiple cancer types. The Swiss pharmaceutical company said Tuesday that…
Read more Roche's Cancer Injection Tecentriq SC Gets European Commission ApprovalBy Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The Swiss pharmaceutical company said Tuesday…
Read more Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage StudyMost patients are unlikely to develop severe disease or die if they get the current variants of COVID-19 as immunity levels have climbed given higher levels of vaccination.…
Read more WHO’s new COVID guidelines see fewer patients requiring hospitalizationPfizer Inc. PFE, -1.73% said Friday that the U.S. Food and Drug Administration has approved the first five-in-one vaccine designed to protect teenagers and young adults against meningococcal…
Read more Pfizer gets FDA green light for new shot that can streamline teenagers’ vaccinationsBristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a deal valued at up to $5.8 billion. The pharmaceutical giant announced it will pay…
Read more Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billionSTOCKHOLM (AP) — Two scientists won the Nobel Prize in medicine on Monday for discoveries that enabled the development of effective mRNA vaccines against COVID-19. The award was…
Read more Nobel Prize in medicine awarded to two scientists whose work enabled creation of mRNA vaccines against COVID-19It may be time to get your COVID-19 vaccine again. There’s a new booster that’s coming out to guard against the virus. The Centers for Disease Control and…
Read more 5 things to know about the new COVID-19 vaccineThe Centers for Disease Control and Prevention on Tuesday recommended updated COVID-19 vaccines for people 6 months of age and older. Director Mandy Cohen late Tuesday backed the…
Read more CDC recommends updated COVID shots for people 6 months of age and olderBy Adria Calatayud Nestle said it has sold its Palforzia peanut-allergy treatment business to biopharmaceutical company Stallergenes Greer. The Swiss consumer-goods company said Monday that it will receive…
Read more Nestle Sells Peanut-Allergy Treatment Business to Stallergenes GreerBy David Sachs Roche said Friday that its Alecensa drug demonstrated the ability to reduce recurrence of lung cancer for patients in the early stage of the disease.…
Read more Roche Lung Cancer Drug Shows Promise in Phase 3 TrialA new variant of the SARS-CoV-2 coronavirus has put epidemiologists around the world on alert, and the World Health Organization is asking countries to sustain early warning, surveillance…
Read more New coronavirus variant has experts on alert and WHO is urging countries to step up COVID surveillanceThe U.S. Food and Drug Administration on Thursday granted full approval to the Biogen BIIB and Eisai Co. Ltd. ESALF Alzheimer’s treatment Leqembi, a step that secures Medicare…
Read more FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverageThat’s a notion that has long fueled hope for many of the more than 40% of Americans who are considered obese — and fueled criticism by those who…
Read more No more needles? A daily pill may work as well as Wegovy shots to treat obesityBy Anthony O. Goriainoff AstraZeneca said Thursday that its and MSD’s Lynparza cancer treatment had been approved in the U.S. for the treatment of metastatic castration-resistant prostate cancer,…
Read more AstraZeneca Says US Approved Lynparza as a Prostate Cancer TreatmentThe U.S. Food and Drug Administration said Tuesday it has granted accelerated approval to Biogen Inc.’s torferson, a treatment for a rare form of amyotrophic lateral sclerosis, or…
Read more Biogen wins accelerated FDA approval for treatment for rare form of ALSModerna Inc. said Tuesday it’s working to develop its first bacterial vaccine to protect against Lyme disease, the tick-borne illness that causes a range of painful symptoms, including…
Read more Moderna is developing a Lyme disease vaccine in a first for the companyPfizer Agrees to Buy Seagen for $43 Billion Source link
Read more Pfizer Agrees to Buy Seagen for $43 BillionRobinhood Markets Inc. accidentally sold short on a small stock as it went on a meme-like ride in December, costing the trading app more than the stock’s current…
Read more Robinhood accidentally sold short on a meme stock and lost $57 millionA Food and Drug Administration advisory panel voted unanimously Thursday for Americans to get a once-a-year booster against COVID-19, with the strain to be decided midyear for a…
Read more FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new casesThe Food and Drug Administration is recommending that the U.S. decide each June which SARS-CoV-2 strains should be included in an annual fall booster shot. Doing so would…
Read more FDA backs annual COVID vaccine for Americans with strain to be decided midyear
